Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Presentation TCT 2019

Aortic Arch Neuromodulation for Chronic Heart Failure: EnoPace

Presenter: Felix Mahfoud

September 28, 2019

Presentation TCT 2019

Update on Target BP Trials Program (Chemical Renal Denervation): Lessons Learned, Ongoing Efforts

Presenter: Felix Mahfoud

September 28, 2019

Presentation TCT 2019

Interventional Therapies for Hypertension: Thinking Outside the Kidney

Presenter: Felix Mahfoud

September 28, 2019

Presentation TCT 2019

Alcohol-Mediated Renal Denervation: 1-Year and Final Results From the Peregrine Postmarket Study

Presenter: Felix Mahfoud

September 27, 2019

Presentation TCT 2019

Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator in Patients with HFrEF and HFpEF: The AFR-PRELIEVE Trial

Presenter: Felix Mahfoud

September 27, 2019

Presentation TCT 2019

Clinical Evaluation: Peregrine Results to Date

Presenter: Felix Mahfoud

September 27, 2019

TCT Shark Tank Innovation Competition Finalists - Early Feasibility of the Metavention Integrated Radio Frequency Nerve Ablation System to Improve Hyperglycemia and Fatty Liver in Type II Diabetic Subjects (Metavention)

Presentation TCT 2019

Early Feasibility of the Metavention Integrated Radio Frequency Nerve Ablation System to Improve Hyperglycemia and Fatty Liver in Type II Diabetic Subjects (Metavention)

Presenter: Felix Mahfoud

September 26, 2019

News Conference News EuroPCR 2019

Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation

L.A. McKeown

June 06, 2019

Advertisement

Aortic Arch Neuromodulation for Chronic Heart Failure: EnoPace

Update on Target BP Trials Program (Chemical Renal Denervation): Lessons Learned, Ongoing Efforts

Interventional Therapies for Hypertension: Thinking Outside the Kidney

Alcohol-Mediated Renal Denervation: 1-Year and Final Results From the Peregrine Postmarket Study

Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator in Patients with HFrEF and HFpEF: The AFR-PRELIEVE Trial

Clinical Evaluation: Peregrine Results to Date

Early Feasibility of the Metavention Integrated Radio Frequency Nerve Ablation System to Improve Hyperglycemia and Fatty Liver in Type II Diabetic Subjects (Metavention)

Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content